CompoAtlas

Rx Omega for Women

Natural health product licensed in Canada

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Huile de poisson

Source : Scombridae - en entier

Potency : 100 mg Docosahexaenoic acid

535 mgNot calculated
Oenothera biennis

Source : Oenothera biennis - Graine

Potency : 25 mg gamma-Linolenic acid

250 mgNot calculated
Huile de poisson

Source : Clupeidae - en entier

Potency : 100 mg Docosahexaenoic acid

535 mgNot calculated
Huile de poisson

Source : Engraulidae - en entier

Potency : 100 mg Docosahexaenoic acid

535 mgNot calculated
Huile de poisson

Source : Scombridae - en entier

Potency : 200 mg Eicosapentaenoic acid

Not specifiedNot calculated
Huile de poisson

Source : Clupeidae - en entier

Potency : 200 mg Eicosapentaenoic acid

Not specifiedNot calculated
Huile de poisson

Source : Engraulidae - en entier

Potency : 200 mg Eicosapentaenoic acid

Not specifiedNot calculated
Linum usitatissimum

Source : Linum usitatissimum - Graine

250 mgNot calculated
Linum usitatissimum

Source : Linum usitatissimum - Graine

Potency : 130 mg alpha-Linolenic acid

Not specifiedNot calculated

Non-medicinal ingredients

Tocophérols, Sorbitol, Eau purifiée, Gélatine, Pectine, Glycérine

PopulationAgeQuantity per servingFrequency
Adults (triacylglycerols/triglycerides)Not specified2 Capsule2 days
Adults (mood balance;omega-6; linolenic acid)Not specified2 Capsule3 days
Adults (rheumatoid arthritis)Not specified2 Capsule5 days
Adultesminimum: 19 years2 Capsuleminimum: 1 day ; maximum: 2 days

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of omega-3 fatty acids, eicosapentaenoic acid (EPA), and/or docosahexaenoic acid (DHA) for the maintenance of good health for women. Helps to maintain/support cardiovascular health. Helps to support cognitive health and/or brain function. Source of alpha-linolenic acid (ALA) for the maintenance of good health. Helps to reduce serum triacylglycerols/triglycerides. Helps to promote healthy mood balance. In conjunction with conventional therapy, helps to reduce the pain of rheumatoid arthritis in adults. Source of essential fatty acids for the maintenance of good health. Source of omega-6 fatty acids for the maintenance of good health. Source of linolenic acid (LA) for the maintenance of good health.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Product record

Other names
Omega-3, Rx Omega-3 Factors, Rx Omega-3 for Women
Licence holder
Natural Factors Nutritional Products Limited
NPN or DIN-HM
80054423
Status
Active licence
Licence date
1 October 2014
Revision date
Not provided
Form
Capsule, molle
Route of administration
Orale
Application type
Non traditionnelle

Source

Official Health Canada record, licence 80054423

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Huile de poisson
    Read the warning, when it applies and the studies cited

    FISH OIL

    Route of administration: Oral

    Cautions and warnings

    Condition of application: Pain of rheumatoid arthritis.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Condition of application: Healthy mood balance.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have psychological disorders such as anxiety or depression.

    Health Canada monograph dated 25 September 2026

  • Oenothera biennis
    Read the warning, when it applies and the studies cited
  • Linum usitatissimum
    Read the warning, when it applies and the studies cited

    FLAXSEED - LINUM USITATISSIMUM

    Route of administration: Oral

    Cautions and warnings

    Applies to products providing 5 g or more of flaxseed per day.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician immediately if you experience chest pain, vomiting, or difficulty swallowing or breathing after taking this product (EMA 2015).

    Sources cited by Health Canada (1)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes or a lazy bowel (EMA 2015; ESCOP 2003).

    Sources cited by Health Canada (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.

    Condition of application: Laxative; Promotion of bowel movement; Constipation.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or if laxative effect does not occur within 7 days (Pray 2006; Repchinsky 2002).

    Sources cited by Health Canada (2)
    • Pray WS. 2006. Non-Prescription Product Therapeutics, 2nd edition. New York (NY): Lippincott Williams & Wilkins.
    • Repchinsky 2002: Canadian Pharmacists Association. Patient Self-Care. Helping Patients Make Therapeutic Choices. Ottawa (ON): Canadian Pharmacists Association.

    Contraindications

    Applies to products providing 5 g or more of flaxseed per day.

    Do not use if you have difficulty swallowing (EMA 2015; ESCOP 2003).

    Sources cited by Health Canada (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.

    Do not use if you have fever or any undiagnosed gastrointestinal trouble (EMA 2015; Gardner and McGuffin 2013; Brinker 2010; ESCOP 2003).

    Sources cited by Health Canada (4)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • ESCOP 2003: ESCOP Monographs: The Scientific Foundation for Herbal Medicinal Products, 2nd edition. Exeter (GB): European Scientific Cooperative on Phytotherapy and Thieme.
    • Gardner Z. and McGuffin M. editors. American Herbal Products Association's Botanical Safety Handbook, 2nd edition. American Herbal Products Association. Boca Raton (FL): CRC Press; 2013.

    Known adverse reactions

    Condition of application: All products.

    Stop use if hypersensitivity/allergy occurs (EMA 2015; León et al. 2003).

    Sources cited by Health Canada (2)
    • EMA 2015. European Medicines Agency. European Union Herbal Monograph on Linum usitatissimum L., semen. London (GB): EMA Committee on Herbal Medicinal Products (HMPC), 10 March 2015. [Accessed 2023 December 31]. Available from: https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-linum-usitatissimum-l-semen_en.pdf
    • León F, Rodríguez M, Cuevas M. 2003. Anaphylaxis to Linum. Allergologia et immunopathologia 31(1):47-49.

    Health Canada monograph dated 26 July 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Rx Omega for Women (Natural Factors Nutritional Products Limited): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80054423-rx-omega-for-women, updated 1 October 2014.

Enter to analyse, Shift+Enter for a new line